Du-Jiang Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Du-Jiang Xie has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ling Zhou
Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
2 shared publications - Ben Huang
Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
1 shared publication - Bing Li
Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68# Changle Road, Nanjing, 210006, China
1 shared publication - Chen Liu
Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68# Changle Road, Nanjing, 210006, China
1 shared publication - Gao-Feng Wang
Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China
1 shared publication Gaofeng Wang
Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 11 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2919
Construction of a Nomogram Prediction Model for Mortality Risk Within 14 Days in Patients with Acute Myocardial Infarction and Ventricular Septal Rupture
Objective: This study aimed to develop a nomogram prediction model for predicting 14-day in-hospital mortality in patients with acute myocardial infarction (AMI) and ventricular septal rupture (VSR). Methods: Clinical data of 86 hospitalized patients (44 survivors and 42 non-survivors within 14 days) were retrospectively collected in Nanjing First Hospital from 1 March 2015 to 7 August 2025. Lasso regression and multivariable logistic regression were used to identify predictors, which were subsequently incorporated into the nomogram development. The model performance was assessed using area under the receiver operating characteristic curve (AUC), calibration plots, decision curve analysis (DCA), and clinical impact curves, with internal validation via 1000 bootstrap resamples. Results: Analysis of lasso regression and multivariable logistic regression analysis identified WBC count (OR = 1.31, 95% CI: 1.01–1.28, p = 0.040), D-dimer level (OR = 1.18, 95% CI: 1.01–1.38, p = 0.043), early revascularization (OR = 0.22, 95% CI: 0.06–0.88, p = 0.032), ventilatory support (OR = 3.48, 95% CI: 1.07–11.29, p = 0.038), and infection (OR = 3.97, 95% CI: 1.02–15.42, p = 0.047) as independent predictors of 14-day mortality for patients. Based on the results, a prediction nomogram model was constructed. The model achieved an area under the receiver operating characteristic curve (AUC) of 0.866 (95% CI: 0.785–0.946), with sensitivity of 0.857 (95% CI: 0.751–0.963) and specificity of 0.818 (95% CI: 0.704–0.932). Calibration plots demonstrated acceptable agreement between predicted and observed probabilities; decision curve analysis (DCA) and clinical impact curve further confirmed its net benefit and clinical utility. By 1000 bootstrap resampling iterations, the model demonstrated an apparent AUC of 0.864, 95% CI: 0.776–0.938, confirming reasonable discriminative performance. Conclusions: In summary, this study developed a clinical interpretable nomogram to estimate short-term (14-day) in-hospital mortality risk in patients with AMI-VSR; it provides a robust and interpretable tool for predicting short-term in-hospital mortality.
- 11 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2919
Open AccessConstruction of a Nomogram Prediction Model for Mortality Risk Within 14 Days in Patients with Acute Myocardial Infarction and Ventricular Septal Rupture
Objective: This study aimed to develop a nomogram prediction model for predicting 14-day in-hospital mortality in patients with acute myocardial infarction (AMI) and ventricular septal rupture (VSR). Methods: Clinical data of 86 hospitalized patients (44 survivors and 42 non-survivors within 14 days) were retrospectively collected in Nanjing First Hospital from 1 March 2015 to 7 August 2025. Lasso regression and multivariable logistic regression were used to identify predictors, which were subsequently incorporated into the nomogram development. The model performance was assessed using area under the receiver operating characteristic curve (AUC), calibration plots, decision curve analysis (DCA), and clinical impact curves, with internal validation via 1000 bootstrap resamples. Results: Analysis of lasso regression and multivariable logistic regression analysis identified WBC count (OR = 1.31, 95% CI: 1.01–1.28, p = 0.040), D-dimer level (OR = 1.18, 95% CI: 1.01–1.38, p = 0.043), early revascularization (OR = 0.22, 95% CI: 0.06–0.88, p = 0.032), ventilatory support (OR = 3.48, 95% CI: 1.07–11.29, p = 0.038), and infection (OR = 3.97, 95% CI: 1.02–15.42, p = 0.047) as independent predictors of 14-day mortality for patients. Based on the results, a prediction nomogram model was constructed. The model achieved an area under the receiver operating characteristic curve (AUC) of 0.866 (95% CI: 0.785–0.946), with sensitivity of 0.857 (95% CI: 0.751–0.963) and specificity of 0.818 (95% CI: 0.704–0.932). Calibration plots demonstrated acceptable agreement between predicted and observed probabilities; decision curve analysis (DCA) and clinical impact curve further confirmed its net benefit and clinical utility. By 1000 bootstrap resampling iterations, the model demonstrated an apparent AUC of 0.864, 95% CI: 0.776–0.938, confirming reasonable discriminative performance. Conclusions: In summary, this study developed a clinical interpretable nomogram to estimate short-term (14-day) in-hospital mortality risk in patients with AMI-VSR; it provides a robust and interpretable tool for predicting short-term in-hospital mortality.
- Open Access
- 3 November 2022
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 39 (3) , 659-666
Comparison of different quantitative evaluation protocols for peri-device leak detection using cardiac computed tomography angiography after left atrial appendage closure
This study seeks to propose and compare different quantitative evaluation methods for identifying patients with peri-device leak (PDL) using cardiac computed tomography angiography (CCTA). Patients who had undergone left atrial appendage (LAA) closure and both transesophageal echocardiography (TEE) and CCTA were enrolled. Hounsfield units (HU) were measured in the proximal and distal regions of the left atrial appendage (p-LAA, d-LAA) on the CCTA, and the average of the two was determined (a-LAA). The relative HU ratios of the LAA to the center of the left atrium (LA) were calculated (p-LAA/c-LA, d-LAA/c-LA, a-LAA/c-LA). The area under the curve (AUC) for the LAA HU and the LAA/LA HU ratio were analyzed and compared. Fifty-one patients were included in this study. Pairwise comparisons showed a statistically significant difference (p = 0.029) in diagnostic performance between the d-LAA (AUC = 0.868) and a-LAA (AUC = 0.972). There were no significant differences between the a-LAA and p-LAA (p = 0.549) or between the d-LAA and p-LAA (p = 0.053). At the optimal cutoff for a-LAA of 115.5 HU, the sensitivity was 100%, the specificity was 88%. At the optimal cutoff for p-LAA of 109 HU, the sensitivity was 100%, the specificity was 84%. The LAA/LA HU ratio did not exhibit better diagnostic performance than HU attenuation in the LAA (p > 0.05). The a-LAA > 115.5 is useful in identifying PDL. Due to its convenience and intuitiveness, p-LAA > 109.0 can also be used as an alternative protocol for a-LAA.
- 3 November 2022
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 39 (3) , 659-666
Open AccessComparison of different quantitative evaluation protocols for peri-device leak detection using cardiac computed tomography angiography after left atrial appendage closure
This study seeks to propose and compare different quantitative evaluation methods for identifying patients with peri-device leak (PDL) using cardiac computed tomography angiography (CCTA). Patients who had undergone left atrial appendage (LAA) closure and both transesophageal echocardiography (TEE) and CCTA were enrolled. Hounsfield units (HU) were measured in the proximal and distal regions of the left atrial appendage (p-LAA, d-LAA) on the CCTA, and the average of the two was determined (a-LAA). The relative HU ratios of the LAA to the center of the left atrium (LA) were calculated (p-LAA/c-LA, d-LAA/c-LA, a-LAA/c-LA). The area under the curve (AUC) for the LAA HU and the LAA/LA HU ratio were analyzed and compared. Fifty-one patients were included in this study. Pairwise comparisons showed a statistically significant difference (p = 0.029) in diagnostic performance between the d-LAA (AUC = 0.868) and a-LAA (AUC = 0.972). There were no significant differences between the a-LAA and p-LAA (p = 0.549) or between the d-LAA and p-LAA (p = 0.053). At the optimal cutoff for a-LAA of 115.5 HU, the sensitivity was 100%, the specificity was 88%. At the optimal cutoff for p-LAA of 109 HU, the sensitivity was 100%, the specificity was 84%. The LAA/LA HU ratio did not exhibit better diagnostic performance than HU attenuation in the LAA (p > 0.05). The a-LAA > 115.5 is useful in identifying PDL. Due to its convenience and intuitiveness, p-LAA > 109.0 can also be used as an alternative protocol for a-LAA.
- Open Access
- 10 October 2016
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 16 (1) , 1-10
Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system
Pulmonary arterial hypertension (PAH) is commonly accompanied with the activation of the renin-angiotensin-aldosterone system (RAAS). Renal sympathetic denervation (RSD) reduces PAH partly through the inhibition of RAAS. Analogically, we hypothesized that pulmonary artery denervation (PADN) could reverse PAH and PAH-induced right ventricular (RV) dysfunction by downregulating the local RAAS activity. Twenty-five beagle dogs were randomized into two groups: control group (intra-atrial injection of N-dimethylacetamide, 3 mg/kg, n = 6) and test group (intra-atrial injection of dehydrogenized-monocrotaline, 3 mg/kg, n = 19). Eight weeks later, dogs in the test group with mean pulmonary arterial pressure (mPAP) ≥25 mmHg (n = 16) were reassigned into the sham (n = 8) and PADN groups (n = 8) by chance. After another 6 weeks, the hemodynamics, pulmonary tissue morphology and the local RAAS expression in lung and right heart tissue were measured. PADN reduced the mPAP (25.94 ± 3.67 mmHg vs 33.72 ± 5.76 mmHg, P < 0.05) and the percentage of medial wall thickness (%MWT) (31.0 ± 2.6 % vs 37.9 ± 2.8 %, P < 0.05) compared with the sham group. PADN attenuated RV dysfunction, marked with reduced atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and ratio of right ventricular to left ventricular plus septum weight [RV/(LV + S)]. Moreover, the local RAAS expression was activated in PAH dogs while inhibited after PADN. PADN improves hemodynamics and relieves RV dysfunction in dogs with PAH, which can be associated with the downregulating RAAS activity in local tissue.
- 10 October 2016
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 16 (1) , 1-10
Open AccessPulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system
Pulmonary arterial hypertension (PAH) is commonly accompanied with the activation of the renin-angiotensin-aldosterone system (RAAS). Renal sympathetic denervation (RSD) reduces PAH partly through the inhibition of RAAS. Analogically, we hypothesized that pulmonary artery denervation (PADN) could reverse PAH and PAH-induced right ventricular (RV) dysfunction by downregulating the local RAAS activity. Twenty-five beagle dogs were randomized into two groups: control group (intra-atrial injection of N-dimethylacetamide, 3 mg/kg, n = 6) and test group (intra-atrial injection of dehydrogenized-monocrotaline, 3 mg/kg, n = 19). Eight weeks later, dogs in the test group with mean pulmonary arterial pressure (mPAP) ≥25 mmHg (n = 16) were reassigned into the sham (n = 8) and PADN groups (n = 8) by chance. After another 6 weeks, the hemodynamics, pulmonary tissue morphology and the local RAAS expression in lung and right heart tissue were measured. PADN reduced the mPAP (25.94 ± 3.67 mmHg vs 33.72 ± 5.76 mmHg, P < 0.05) and the percentage of medial wall thickness (%MWT) (31.0 ± 2.6 % vs 37.9 ± 2.8 %, P < 0.05) compared with the sham group. PADN attenuated RV dysfunction, marked with reduced atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and ratio of right ventricular to left ventricular plus septum weight [RV/(LV + S)]. Moreover, the local RAAS expression was activated in PAH dogs while inhibited after PADN. PADN improves hemodynamics and relieves RV dysfunction in dogs with PAH, which can be associated with the downregulating RAAS activity in local tissue.